Check Cap Stock Price

-0.0474 (-8.37%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Check Cap Ltd CHEK NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.0474 -8.37% 0.5186 0.501 0.566 0.566 0.566 13:17:05
Bid Price Ask Price Spread Spread % News
0.516 0.5186 0.0026 0.5% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,987 5,757,552 $ 0.531833 $ 3,062,056 6,581,741 0.44 - 2.37
Last Trade Time Type Quantity Stock Price Currency
13:17:00 2,000 $ 0.5186 USD

Check Cap Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.81M 30.17M 8.13M $ - $ - -3.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Check Cap News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CHEK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.67090.6890.5010.61875054,868,573-0.1523-22.7%
1 Month0.570.90240.5010.6410968,241,830-0.0514-9.02%
3 Months0.590.90240.500.62133734,599,864-0.0714-12.1%
6 Months1.741.920.440.60369933,024,499-1.22-70.2%
1 Year2.002.370.440.6269711,529,732-1.48-74.07%
3 Years20.4024.000.442.15688,128-19.88-97.46%
5 Years42.0045.600.443.80448,642-41.48-98.77%

Check Cap Description

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.

Your Recent History
Check Cap
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.